CMS Updates Medicare Advantage and Part D (Prescription Drug ...

JD Supra (press release)-5 hours ago

The clinical guidelines for determining whether a beneficiary is potentially at-risk (based on using opioids from multiple prescribers and/or multiple pharmacies) will be expanded. Sponsors will be allowed to “lock in” an at-risk beneficiary's access to frequently abused drugs to selected prescribers and/or pharmacies.